Medison Pharma Australia Pty Ltd.

ACTIVE

AustraliaPrivate

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

No trial data available

Clinical Trials

No trial data available

Approvals

Approvals by Agency

TGA

Therapeutic Goods Administration

Approvals

Recent Approvals

OXLUMO lumasiran (as sodium) 94.5 mg/0.5 mL injection vial. (421050)

TGA

2024-06-24

OXLUMO lumasiran (as sodium) 94.5 mg/0.5 mL injection vial. (421050)

TGA

2024-06-24

AMVUTTRA, vutrisiran (as sodium) 25 mg / 0.5 mL solution for injection pre-filled syringe (422290)

TGA

2024-06-21

AMVUTTRA, vutrisiran (as sodium) 25 mg / 0.5 mL solution for injection pre-filled syringe (422290)

TGA

2024-06-21

GIVLAARI givosiran 189 mg/1mL solution for injection vial (401153)

TGA

2023-11-28

GIVLAARI givosiran 189 mg/1mL solution for injection vial (401153)

TGA

2023-11-28

ONPATTRO patisiran 10 mg/5 mL concentrated injection for infusion vial (380813)

TGA

2022-11-21

ONPATTRO patisiran 10 mg/5 mL concentrated injection for infusion vial (380813)

TGA

2022-11-21

KIMMTRAK tebentafusp 0.1 mg/0.5 mL concentrated solution for infusion vial (375296)

TGA

2022-06-03

KIMMTRAK tebentafusp 0.1 mg/0.5 mL concentrated solution for infusion vial (375296)

TGA

2022-06-03

News

No news articles found

Back to Organizations